7/31/09 update No doubt, tuckered out from their battles earlier in the month, both Bulls & Bears took a bit of a siesta in July's final week. The Nasdaq Composite Index was up 25.89% CYTD, or Contest Year To Date, (vs. up 25.09% CYTD a week ago), the Nasdaq Biotech Index closed up 13.60% CYTD (vs. up 12.30% CYTD a week ago), while our marvelous Contest median closed up 30.06% CYTD (vs. up 29.86% CYTD a week ago). We have a new leader! Although RKRW's portfolio closed the week with more than a double, super-charged GENE's portfolio glided right by into first place, with MIKE's portfolio holding on to third place. The week's closing CYTD percentages are: GENE up an amazing 115.41%, RKRW up 101.29%, MIKE up 87.13%. At Friday's close, an impressive 28 of the 32 Contest portfolios were in the black and 21 of the 32 were beating the NBI. Have a wonderful weekend folks! Below is the Top Ten list on 7/31/09:
7/31/09 Rank Name Profit/Loss 1 GENE 115,411 2 RKRW 101,293 3 MIKE 87,134 4 NIGEL 68,557 5 BULBA 66,236 6 ASHLEY 57,911 7 GEORGIA 52,837 8 MOPGCW 48,830 9 SCARAM 46,776 10 ENZYME 44,699
(All corrections, especially adjustments for splits, greatly appreciated.) |